Jump to content

Cannabipiperidiethanone

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Dcirovic (talk | contribs) at 19:44, 28 May 2016 (→‎top: clean up using AWB). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Cannabipiperidiethanone
Identifiers
  • 2-(2-methoxyphenyl)-1-[1-([1-methylpiperidin-2-yl]methyl)indol-3-yl]ethanone
CAS Number
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC24H28N2O2
Molar mass376.490 g/mol g·mol−1
3D model (JSmol)
  • COc2ccccc2CC(=O)c(c4c1cccc4)cn1CC3CCCCN3C
  • InChI=1S/C24H28N2O2/c1-25-14-8-7-10-19(25)16-26-17-21(20-11-4-5-12-22(20)26)23(27)15-18-9-3-6-13-24(18)28-2/h3-6,9,11-13,17,19H,7-8,10,14-16H2,1-2H3
  • Key:AJSBNWAHEDVQJT-UHFFFAOYSA-N

Cannabipiperidiethanone, (CPE, or 1-(N-methylpiperidin-2-ylmethyl)-3-(2-methoxyphenylacetyl)indole), is a synthetic cannabinoid that has been found as an ingredient of "herbal" synthetic cannabis blends sold in Japan, alongside JWH-122 and JWH-081. Its binding affinity was measured at the CB1 and CB2 receptors and it was found to have an IC50 of 591nM at CB1 and 968nM at CB2, making it 2.3x and 9.4x weaker than JWH-250 at these two targets respectively.[1]

See also

References

  1. ^ Uchiyama N, Kikura-Hanajiri R, Goda Y (2011). "Identification of a novel cannabimimetic phenylacetylindole, cannabipiperidiethanone, as a designer drug in a herbal product and its affinity for cannabinoid CB₁ and CB₂ receptors". Chemical & Pharmaceutical Bulletin. 59 (9): 1203–5. doi:10.1248/cpb.59.1203. PMID 21881274.